Compare Davita Inc (DVA) vs Sezzle Inc (SEZL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Davita Inc vs Sezzle Inc — how do they compare? Davita Inc trades at $179.46 (market cap $11.38B), while Sezzle Inc trades at $124.66 (market cap $4.32B). The key difference: Davita Inc is far larger — about 2.6× Sezzle Inc's market cap. Which is the better fit depends on your goals.
| DVA | SEZL | |
|---|---|---|
Market Cap | $11.38B | $4.32B |
Sector | Health | Technology |
52-Week High | $240.96 | $188.55 |
52-Week Low | $103.87 | $50.97 |
Enterprise Value | $24.10B | $4.36B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $183.69, down slightly by 0.04% over the past day. The stock shows strong fundamental performance with consistent earnings beats in recent quarters, including Q2 2026 EPS of $4.02 versus $3.88 expected (Zacks Investment Research, 2026-08-04). However, technical indicators signal a bearish trend, with the price near key support at $182. Revenue growth remains steady, climbing to $13.64 billion in 2025, though net income margin dipped to 5.47%.
The outlook is mixed; analyst consensus leans bullish with a $232.25 price target (MarketBeat, 2026-08-05), but risks include reimbursement pressure and high debt levels. Investment appeal hinges on execution against guidance amid payer-mix challenges, with the current valuation offering potential upside if operational trends stabilize.
SEZL stock trades at $125.81, up 6.62% with strong quarterly earnings beats and raised 2026 guidance. The company demonstrates robust fundamentals with 30.35% net income margin and 88.85% ROE, though technical indicators show bearish momentum with current price near support at $125. Recent institutional buying and positive analyst coverage (50% buy ratings) support the growth narrative despite elevated valuation multiples.
The outlook remains positive given consecutive earnings beats and 35% revenue growth guidance, though the stock faces technical headwinds and premium valuation risks. Execution on AI initiatives and everyday money expansion could drive further upside toward the $158.29 consensus target, but investors should monitor margin pressures and competitive threats in the BNPL space.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Davita Inc
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →About Sezzle Inc
Sezzle Inc is a financial technology company that operates a Buy Now, Pay Later (BNPL) payment platform. The company allows consumers to make purchases and split the total cost into four interest-free payments over six weeks, primarily serving the e-commerce retail market. Sezzle focuses on promoting financial empowerment by offering a transparent and responsible payment solution to customers at the point of sale.
Read more on SEZL →
